| P50 | author | Soroush Sardari | Q42170695 |
| P2093 | author name string | Mahdieh Gaeini | |
| | Maria Abedinzadeh | |
| P2860 | cites work | Antimicrobial peptides for therapeutic applications: a review | Q27004635 |
| | The future of peptide-based drugs | Q28281702 |
| | Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis | Q28302775 |
| | Antimycobacterial activities in vitro and in vivo and pharmacokinetics of dihydromycoplanecin A | Q28361413 |
| | Antimicrobial peptides: an overview of a promising class of therapeutics | Q29012080 |
| | Antimicrobial evaluation of nocathiacins, a thiazole peptide class of antibiotics | Q31115498 |
| | Mechanisms of antimicrobial peptide action and resistance | Q34181099 |
| | Novel cyclic lipodepsipeptide from Pseudomonas syringae pv. lachrymans strain 508 and syringopeptin antimicrobial activities | Q34228389 |
| | Pitipeptolides C-F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam. | Q35223663 |
| | Antimycobacterial natural products | Q35618520 |
| | New drug candidates and therapeutic targets for tuberculosis therapy | Q36396522 |
| | In vitro and in vivo evaluation of select kahalalide F analogs with antitumor and antifungal activities | Q36470946 |
| | Current status of TB vaccines | Q36744717 |
| | Solid-phase total synthesis of kahalalide A and related analogues. | Q37029182 |
| | Role of antimicrobial peptides in host defense against mycobacterial infections | Q37200939 |
| | New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development | Q37346929 |
| | Total synthesis of hirsutellone B. | Q37409506 |
| | Bioprospecting for antituberculosis leads from microbial metabolites. | Q37797910 |
| | Natural roles of antimicrobial peptides in microbes, plants and animals. | Q37841814 |
| | Designing antimicrobial peptides: form follows function. | Q37968899 |
| | Recent advances in antitubercular natural products. | Q37978974 |
| | Efficacy of antimicrobial peptoids against Mycobacterium tuberculosis | Q39564647 |
| | Identification of the nonribosomal peptide synthetase gene responsible for bassianolide synthesis in wood-decaying fungus Xylaria sp. BCC1067. | Q39997108 |
| | Cytotoxicity of enniatins A, A1, B, B1, B2 and B3 from Fusarium avenaceum | Q40274903 |
| | Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy | Q40513871 |
| | Microcionamides A and B, bioactive peptides from the philippine sponge Clathria (Thalysias) abietina | Q40549445 |
| | Hirsutellide A, a new antimycobacterial cyclohexadepsipeptide from the entomopathogenic fungus Hirsutella kobayasii. | Q40701229 |
| | Antibacterial activity of human neutrophil peptide-1 against Mycobacterium tuberculosis H37Rv: in vitro and ex vivo study | Q40863365 |
| | Conserved structure and function in the granulysin and NK-lysin peptide family. | Q42287593 |
| | Massetolides A-H, antimycobacterial cyclic depsipeptides produced by two pseudomonads isolated from marine habitats | Q42549491 |
| | Roles of hydrophobicity and charge distribution of cationic antimicrobial peptides in peptide-membrane interactions. | Q42605386 |
| | The natural product cyclomarin kills Mycobacterium tuberculosis by targeting the ClpC1 subunit of the caseinolytic protease | Q42740574 |
| | Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria | Q43024258 |
| | Antimycobacterial and antiplasmodial cyclodepsipeptides from the insect pathogenic fungus Paecilomyces tenuipes BCC 1614. | Q43528781 |
| | Pitipeptolides A and B, new cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula | Q43558774 |
| | In vitro activities of small peptides from snake venom against clinical isolates of drug-resistant Mycobacterium tuberculosis | Q44555746 |
| | In vitro and ex vivo activity of peptide deformylase inhibitors against Mycobacterium tuberculosis H37Rv. | Q45977956 |
| | Cyclohexadepsipeptides from the insect pathogenic fungus Hirsutella nivea BCC 2594. | Q51314944 |
| | An antimycobacterial cyclodepsipeptide from the entomopathogenic fungus Ophiocordyceps communis BCC 16475. | Q52700458 |
| | In vitro activity of PR-39, a proline-arginine-rich peptide, against susceptible and multi-drug-resistant Mycobacterium tuberculosis. | Q54011351 |
| | Ziziphine N, O, P and Q, new antiplasmodial cyclopeptide alkaloids from Ziziphus oenoplia var. brunoniana | Q57532754 |
| | Lydiamycins A–D: Cyclodepsipetides with Antimycobacterial Properties | Q78230922 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| | antimicrobial peptide | Q1201508 |
| P304 | page(s) | 1285-1289 | |
| P577 | publication date | 2015-05-01 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Natural antimicrobial peptides against Mycobacterium tuberculosis | |
| P478 | volume | 70 | |